Obesity has reached epidemic proportions globally, with more than 1 billion adults overweight -at least 300 million of them clinically obese. In Ayurveda, obesity is called 'medoroga'. The detailed features and treatments of the disease have been described in an old Ayurvedic text, Charak and Sushrut Samhita. There are some native plants that are commonly used for the treatment of obesity in Ayurveda. Unfortunately, only few medications are available in the market, with side effects and unacceptable efficacy. With the current view that botanical drugs can be developed faster and more cheaply than conventional single entity pharmaceuticals, the review mainly focuses on the rationality of their use with appropriate literature data support.
The past 20 years have seen a dramatic increase in the prevalence of obesity, which has prompted tremendous health concerns. Although widely regarded as a problem almost exclusively confined to the developed world (with its fast food and sedentary lifestyle), the obesity 'epidemic' is in reality sweeping inexorably through the non-industrialized countries [1, 2] . Obesity is recognized as a chronic and stigmatized, epidemic condition that affects populations globally, with more than 1 billion adults overweight -at least 300 million of them clinically obese, and is a major contributor to the global burden of chronic disease and disability. The World Health Organization (WHO) estimates that if this current trend continues, the number will increase to 1.5 billion by 2015 [2] . In the US, 65% of adults (~127 million people) are either overweight or obese (Figure1) [3] . The WHO points out that the prevalence of obesity is often increasing at a faster rate in developing countries than in the developed world -the phenomenon of 'globesity'. Obesity accounts for 2-6% of total health care costs in several developed countries. With the growing prevalence, it is perhaps unsurprising that the worldwide obesity market has been predicted to reach US$ 3.7 billion by 2008 [1] . A similar situation exists in the Indian populace as well; however, no official figures are available. (20-74 years) Physiologically, obesity is a disorder of energy balance. A positive energy balance sustains inside the body due to imbalance between satiety control and energy expenditure controlled by several biological factors [4] . That excess energy is stored as body fat inside the adipose tissue. Obesity (BMI>30 kg/m 2 ) and overweight (25< BMI >30 kg/m 2 ) are important risk factors for cardiovascular diseases, which account for over 17 million deaths every year [2, 5] .
The aetiology of obesity is regarded as complex, consisting of the interaction of a variety of genetic, metabolic, environmental and behavioral factors. Overeating, sedentary habits and genetic factors are mainly responsible for obesity. Hyperlipidemia is a very closely related metabolic disorder, mainly caused by high fatty dietary intake. Blood cholesterol or triglyceride levels or both may be increased in hyperlipidemic persons. These two diseases may develop several other metabolic disorders like Type II diabetes, hypertension, and pancreatitis and raise the risk of morbidity from various circulatory disorders like formation of atherogenic plaques and certain types of cancer [1, 6] .
Unfortunately, though the prevalence of obesity is increasing at an alarming rate, only few medications are available in the market, with known side effects and generally low efficacy. Till now, only two medications have been approved by the Food and Drug Administration for long-term use, namely orlistat, a pancreatic lipase inhibitor, and Sibutramine, a serotonin uptake inhibitor. Four others, diethylpropion, phentermine, phendimetrazine, and benzphetamine, are approved by the FDA for short-term use [3, 7] . As these drugs have several side effects, newer drugs with fewer or no side effects are a required. Besides increased awareness of the associated health risks of obesity, there has been a rapid increase in the understanding of biochemical events thought to be causative factors. The subsequent discovery of the importance of specific anabolic and catabolic circuits in the brain that control energy homeostasis has helped in the research for obesity treatments on specific molecular targets. Novel perceptions of the risks and causes of obesity have consequently been a stimulus for the development of pharmaceutical approaches to the reduction of body adipose tissue and to the prevention of its gain [8] [9] [10] . Table 1 lists the various molecular targets that have been identified for the development of antiobesity drugs [8, 9] while Table 2 gives the status of some of the drugs that are at different phases of clinical trials [3] . The general strategies in developing an antiobesity drug involves reduction of energy intake by either increasing satiety or altering the relative dietary preferences for complex carbohydrates relative to fat, thermogenesis or increasing energy expenditure, interfering energy utilization and reducing the absorption of nutrients from the gastrointestinal tract [11] . 
Antiobesity and Lipid Lowering Plants
The Indian ancient text Ayurveda describes various natural treatments of obesity and hyperlipidemia. Two Ayurvedic classics (Ayurveda-part of Atharbaveda; 'Ayu' means life and 'Veda' means knowledge), Charak Samhita and Sushrut Samhita have described the detailed description of various diseases and their treatments, including obesity and [12] .
All over the world, more than 50 individual dietary supplements and 125 proprietary products already exist in the market for weight loss [13] . In recent years, the popularity of complementary medicines has increased considerably. [14] . The current review mainly focuses on the rationality of their use in the discovery of newer antiobesity agents with appropriate literature data support.
Plants with Pancreatic Lipase Inhibition Potential
Pancreatic lipase (PL) is a key enzyme for lipid breakdown to absorb fatty acids. PL, one of the exocrine enzymes of pancreatic juice, catalyzes the hydrolysis of emulsified esters of glycerol and longchain fatty acids. Short-chain fatty acids can be directly absorbed into the blood, while long-chain fatty acids and monoglycerides combine with bile salts to form water-soluble micelles. The micelles are absorbed into the mucosal cells of the intestine, and the fatty acids and monoglycerides are resynthesized into triglycerides. Dietary triglyceride is usually stored in the adipose tissue. Pharmacological agents that reduce the absorption of dietary triglyceride are under development for antiobesity treatment [16] . As part of the continuing search for biologically active antiobesity agents from natural herbal resources, various plants have been screened for their antilipase activity.
Vitis vinifera (Vitaceae):
A great deal of research effort is being devoted to testing the putative beneficial effects of grape polyphenols extracted from grape seeds and widely used as nutrition supplements. The results from several studies have indicated a lack of toxicity and support the use of a proanthocyanidin-rich extract from grape seeds for various foods. The Grape Seed Extract (GSE) rich in bioactive phytochemicals showed inhibitory activity on the fat-metabolizing enzymes pancreatic lipase and lipoprotein lipase, thus suggesting that GSE might be useful as a treatment to limit dietary fat absorption and the accumulation of fat in adipose tissue. The observed reduction in intracellular lipolytic activity of cultured 3T3-L1 adipocytes may reduce the levels of circulating free fatty acids that have been linked to insulin resistance in obese patients. The effect of the GSE on lipases may be caused by a synergistic action of several compounds within the extract, rather than by a single compound. These flavonoids, procyanidins and their antioxidative metabolites have the potential to be obesity-preventive agents [17] .
Oolong tea: Three kinds of tea: oolong, green and black, have been widely used as health drinks from ancient times all over the world, especially to prevent obesity and to improve lipid metabolism. Among the three teas, oolong tea is traditionally reported to have antiobesity and hypolipidaemic actions. Oolong tea might exert its anti-obesity action through inhibition of intestinal absorption of dietary fat, acceleration of lipolysis in adipose tissue and other mechanisms. The antiobesity action of oolong tea is attributed to the enhancing effect of caffeine (1) on noradrenalineinduced lipolysis in adipose tissue and to the inhibitory effects of teasaponin on pancreatic lipase activity. Teasaponin (a mixture of theasaponins E 1 and E 2 ) isolated from oolong tea inhibited pancreatic lipase in vitro. Furthermore, teasaponins also prevented high fat diet induced obesity in vivo [18, 19] .
Oolong tea contains a variety of polyphenols that have been shown to have potent pancreatic lipase inhibitory activity in vitro. Among these polyphenols, (-)-epigallocatechin 3,5-di-Ogallate (2) (IC 50 .098 µM), prodelphinidin B-2 3,3'-di-O-gallate (3) (IC 50 0.107 µM), assamicain A (4) (IC 50 0.120 µM), oolonghomobisflavan A (5) (IC 50 0.048 µM), oolonghomobisflavan B (6) (IC 50 0.108 µM), theasinensin D (7) (IC 50 0.098 µM), oolongtheanin 3'-O-gallate (8) (IC 50 0.068 µM), theaflavin (9) (IC 50 0.106 µM), and theaflavin 3,3'-O-gallate (10) (IC 50 0.092 µM) showed the most potent inhibitory activity. From these studies the SAR was developed and it was shown that flavan-3-ol gallate esters largely contributed to the inhibitory activity. Further, the dimeric compounds of the flavan-3-ol gallate esters of epigallocatechin gallate (EGCG) and gallocatechin gallate (GCG), such as proanthocyanidins, oolonghomobisflavan, theasinensins and theaflavons, have stronger activity than EGCG and GCG. Thus it was suggested that the functional galloyl moieties in the structure and the polymerization of flavan-3-ol were needed for the expression of lipase inhibition [20] .
Platycodon grandiflorum (Campanulaceae):
This plant is edible and widely used in traditional Oriental medicines as an expectorant for pulmonary diseases and as a remedy for respiratory disorders. Platycodin saponins (PS) are the primary constituents of Platycodi Radix, responsible for a diversity of effects, including anti-inflammation, anti-allergy, anti-tumor, augmentation of immune response, and stimulating apoptosis in skin cells. In China and Korea, pickled fresh roots of P. grandiflorum are consumed to prevent obesity. An aqueous extract of Platycodi radix showed inhibitory pancreatic lipase activity in vitro. Thus, the antiobesity action of Platycodi radix may be due to the inhibition of intestinal absorption of dietary fats. Furthermore, the aqueous extract was also screened in a high fat diet induced obesity model in mice and shown to prevent body weight gain [21, 22] . Pancreatic lipase inhibitory activity of the Platycodon radix is attributed to the saponins present in the extract. Various triterpenoid saponins from Platycodi radix have been isolated and shown to have pancreatic lipase inhibitory activity. PS have been shown to produce profound effects on the control of obesity and lipid metabolism, which resulted in LDL-cholesterol reduction.
PS also cause reduction in calorie intake, which may be correlated to the body weight loss [23] [24] [25] . Among the various saponins isolated, platycodin D (11) showed the strongest pancreatic lipase inhibitory activity. Platycodin D inhibits the pancreatic lipase activity in a competitive manner, with the value for KI being 0.18b ± 0.02 mM [23] . These results suggest that PS have a greater role in antiobesity and hyperlipidemia. Hence, PS could be a potential therapeutic alternative in the treatment of obesity and hyperlipidemia [24, 25] .
Gardenia jasminoides (Rubiaceae):
Gardenia jasminoides is widely used traditionally for its homeostatic, antiphlogistic, analgesic and antipyretic effects. Gardenia fructus (GF) water extract has been shown to inhibit pancreatic lipase activity. The compounds isolated from GF, crocetin (12) and crocin (13) , showed significant inhibition of pancreatic lipase and lipoprotein lipase, as well as of the lipolysis of 3T3-L1 adipocytes. These compounds also showed hypolipidemic activity in hyperlipidemic mice induced by high cholesterol, high fat and high carbohydrate diets [26] .
Cassia nomame (Leguminosae): C. nomame has been shown to have lipase inhibitory activity. Luteolin (14) , isolated from its leaves, and several polyphenols also inhibited the pancreatic lipases. CT-II, a fraction of the aqueous ethanol extract of Nomame Herba, containing primarily proanthocyanidin (condensed tannin), showed a remarkable inhibitory effect on pancreatic lipase activity in vitro and also showed anti-obesity effects in rats fed a high-fat diet in vivo [27] . Further investigation of lipase-inhibiting substances in fruits revealed that several constituents related to condensed tannins have the inhibitory activity. Among the compounds tested, (2S)-3',4',7trihydroxyflavan-(4?? 8)-catechin (15) showed the most potent inhibitory effect on lipase (IC 50 , 5.5 µM) in vitro [28] . Salvia officinalis (Lamiaceae): The methanolic extract of the leaves of S. officinalis (sage) showed a significant inhibitory effect on the serum triglyceride elevation in olive-oil loaded mice in vivo and significant inhibitory activity (IC 50 : 94 µg/mL) against pancreatic lipase. Bioactive guided fractionation of the active extract led to the isolation of abietan type diterpenes viz. carnosic acid (16) , carnosol (17) , royleanonic acid, 7-methoxyrosmanol and a triterpene, oleonolic acid. Among these compounds, carnosic acid and carnosol significantly inhibited pancreatic lipase activity with IC 50 values of 36 µM and 13 µM respectively. Furthermore, carnosic acid reduced the body weight gain and the accumulation of epididymal fat in high fat diet mice at a dose of 20 mg/kg/day, by oral administration [29] .
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Arachis hypogaea (Fabaceae):
Arachis hypogaea or peanut shell has been reported to have hypoglycemic and hypolipidemic actions. The extract also has been shown to prevent body weight gain induced by high fat diet to male wistar rats. These effects are likely to have been induced by more than one bioactive component of peanut shell extract (PSE). The relative biochemical complexity of this extract may result in a pleiotropic action on several lipid metabolism targets simultaneously. Thus, PSE is a promising candidate for a novel multifunctional weight control botanical therapeutic [30] . 
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Salacia reticulata (Hippocrateaceae): The roots and stems of S. reticulata have been used as a supplementary food to prevent obesity and diabetes. A hot water soluble extract of S. reticulata roots (SRHW) has been evaluated for its antiobesity effects using obese rat models and an in vitro study. SRHW showed a strong pancreatic lipase inhibition in vitro. It also prevented weight gain in high fat diet mice. Further, the polyphenols, diterpenes and triterpenes and salacinol (25) isolated from the roots of S. reticulata, also examined for their effects on lipid metabolizing enzymes and lipolysis, were shown to be involved in the antiobesity effects of SRHW [32] . (26) and chiisanoside (27) , showed strong pancreatic lipase inhibitory activity in vitro. Consequently, it is suggested that lupane-type saponins from the leaves of A. sessiliflorus would be candidates for a mild and safe treatment to prevent and reduce obesity [33] .
Panax japonicus (Araliaceae): The rhizomes of P. japonicus (Japanese name; Chikusetsuninjin) have been used as a substitute for Ginseng roots (the roots of P. ginseng C.A. Meyer). On the other hand, Ginseng roots are used as the remedy for life-stylerelated diseases, such as arteriosclerosis hyperlipidemia, hypertension and non-insulindependent diabetes mellitus in China, Korea, Japan and Europe. The saponin fractions of P. japonicus rhizomes have shown a significant anti-obesity action supporting its traditional usage. The active components, chikusetsusaponins III (28) and IV (29) , and deglucosyl-chikusetsusaponins IV (30) and V (31) have a potent pancreatic lipase inhibitory activity in vitro. Total chikusetsusaponins isolated from P. japonicus may prevent high fat diet-induced increases in body weight and fat storage in adipose tissue by inhibiting intestinal absorption of dietary fat through the inhibition of pancreatic lipase activity, Hence it might help in preventing obesity complications and serve as a good adjuvant in the present armamentarium of anti-obesity drugs [34] .
Alpinia officinarum (Zingiberaceae): The ethyl acetate fraction of the aqueous extract of A. officinarum rhizome showed a potent antilipase activity. From this fraction two compounds, 3-methyletherganglin (32) and 5-Hydroxy-7-(4'hydroxy-3'-methoxyphenyl)-1-phenyl-3-heptanone (33) , have been isolated with significant pancreatic lipase inhibitory activity in vitro. These compounds also showed potent hypolipidemic activity in Triton WR-1339-induced hyperlipidemic mice [35, 36] . Spirulina platensis (Oscillatoriaceae): Commonly known as Spirulina algae, it contains phenylalanine, which is purported to inhibit appetite. Though in 1981, the FDA declared Spirulina ineffective for weight loss [9] , recently, the aqueous extract of S. platensis has been reported to inhibit the intestinal absorption of dietary fat by inhibiting pancreatic lipase activity. It was also shown to be effective in reducing the elevated rat plasma triacylglycerol levels in mice. Glycolipid H-b2 (34) and phycocyanin were found to be the active components and inhibited the pancreatic lipase activity in a dose dependant manner [37] Recently, several plants from Korean traditional medicine were screened for their inhibitory action on pancreatic lipase in search of new antiobesity leads. [40] .
Plants with DGAT Inhibition Potential
Triacylglycerol (TG) is the major storage form of energy in mammalian cells. However, excessive deposition of TG in various tissues leads to obesity and is associated with tissue dysfunction referred to as lipotoxicity. TG synthesis has been assumed to occur primarily through diacetylglycerol acyltransferase (DGAT) that catalyzes the final step in the glycerol phosphate pathway. Two types of DGAT enzymes have been identified as DGAT1 and DGAT2. DGAT1 is considered as the more potent target for the treatment of obesity, hypertriglyceridemia and type 2 diabetes. Thus inhibition of DGAT provides another potential target in the development of antiobesity therapeutics. This review gives an account of some of the plants that have been screened and found to inhibit DGAT [41] .
Alnus hirsuta (Betulaceae):
A methanolic extract of the bark of A. hirsuta inhibits DGAT enzyme activity (50.4% inhibition at 125 µg/mL). The marker compound, betulinic acid (35) , was shown to inhibit the enzyme activity in a concentration dependant manner with an IC 50 value of 9.6 µM. Betulinic acid was found to be a non competitive inhibitor of rat liver DGAT enzyme and TG synthesis in human HepG2 cells. Therefore, the compound may be useful for the design of a new DGAT inhibitor leading to antiobesity agents [42] . Sophora flavescens (Fabaceae): S. flavescens has been shown to have an inhibitory effect on DGAT activity. Various prenylflavonoids from this plant have been isolated and shown to have good activity against DGAT in a concentration dependant manner. Among these, the flavonoids, kurarinone (36), kuraridin (37) and kurarinol (38) have shown strong inhibition of DGAT, with IC 50 values of 10.9 µM, 9.8 µM and 8.6 µM, respectively [43] . [44] . Evodiamine (43), a major alkaloid obtained from E rutaecarpa, showed prevention of previsceral fat accumulation and body weight increase in mice and rat antiobesity models, through the enhancement of lipolysis, BAT activation and heat dissipation, resulting in the waste of food energy. These effects of evodiamine are thought to be the result of the activation of the sensory nervous system by binding to the vanilloid receptor [45] .
Salix matsudana (Salicaceae): S. matsudana has been used for more than 3000 years in Chinese folk drugs for the treatment of various disorders. Recently the leaves have been reported to have antiobesity activity. Further, the antiobesity action of the leaves may partly be attributed to its polyphenolic constituents. Three flavonoid glycosides viz. apigenin-7-O-D-glucoside (44), luteolin-7-O-Dglucoside (45) , and chrysoeriol-7-O-D-glucoside (46) have been isolated from the leaves and shown to be active in high fat diet induced obesity mice models. It acts possibly by inhibition of the intestinal absorption of dietary fat and carbohydrates through inhibition of alpha-amylase and palmitic acid uptake into the small intestinal brush order membrane or by accelerating fat mobilization through enhancing norepinephrine induced lipolysis in fat cells [46] .
Salvia miltiorrhiza (Labiatae):
The methanolic extract of S. miltiorrhiza showed potent inhibition of DGAT prepared from the liver membrane of male Sprague-Dawley (SD) rats. Dried root of S. miltiorrhiza (Tan-shen in Chinese) has been commonly used in traditional Chinese medicine for the treatment of coronary heart disease, particularly angina pectoris and myocardial heart infarction. The tanshinones, cryptotanshinone (47) and 15, 16dihydrotanshinone I (48), exhibited potent inhibitory activities, which were dose dependent, with IC 50 values of 10.5 mg/mL and 11.1 mg/mL, respectively. However, tanshinone IIA and tanshinone I showed very weak inhibition (IC 50 value > 250 mg/mL). Structure-activity relationship studies indicated that the compounds with a dihydrofuran moiety are more potent than the corresponding compounds with a furan moiety; a dihydrofuran moiety thus seems to be responsible for the stronger inhibitory activity [47] .
Plants having other mechanisms of action
Ephedra sinica (Ephedraceae): The leaves of this plant contain ephedrine (49), a sympathomimetic drug, which acts through α- and β- adrenoreceptors, and which is an effective weight loss agent that increases thermogenesis and quenches appetite. Metabolite 356, an ephedra-containing product, was the top selling dietary supplement with $70 million in sales a few years ago. However, due to its severe CNS related side effects, the drug was withdrawn from the market [48, 49] .
Citrus aurantium (Rutaceae): C. aurantium, also known as bitter orange or Seville orange, also induces thermogenesis. Fruit extract contains synephrine (50) (0.02-0.35%), octopamine (51) (0.03-0.15%) and phenylephrine (52) (msynephrine). Flowers and leaves are also used. Phenylethanolamine N-methyl transferase catabolizes octopamine into synephrine in vivo. Synephrine activates α- as well as  β 3 -adrenergic receptors. Octopamine appears to be a selective β 3 - adrenoreceptor agonist that has a lipolytic effect in fat cells. High concentrations of synephrine also stimulate lipolysis [13] . C. aurantium would be expected to have sympathomimetic side effects, but severe effects have not been reported to date [50, 51] .
Camellia sinensis (Theaceae): Leaves of C. sinensis or green tea contain high quantities of several polyphenolic compounds like epicatechin, epicatechin gallate, epigallocatechin and epigallocatechin gallate and a high quantity of caffeine. These chemical compounds influence the body thermogenic process acting through different steps of norepinephrine (NE) modulatory pathways [52] . The thermogenic effect of tea is generally attributed to its caffeine content, which is entirely dependent on a sympathetic intervention. Caffeine is also the main constituent of coffee seeds, guarana and kola nut. Caffeine increases resting energy expenditure (BMR), as well as a lipolytic effect in the adipose tissue. Tea polyphenols inhibit NE degradation mediated by catechol-O-methyl transferase (COMT) and prolongs sympathetic activity. Green tea extract (ethanolic extract standardized at 25% catechin, expressed as epigallocatechin gallate) stimulates thermogenesis in brown adipose tissue to an extent that is much greater than that produced by its caffeine content per se, which indicates a synergistic interaction between the above constituents of the extract. Green tea extract has an inhibitory action on gastric and pancreatic lipase and fatty acid synthesis in liver. Other polyphenolic compounds, like tannins and tannic acids, significantly decrease both basal and hormone stimulated lipolysis [53] [54] .
Detailed mechanisms of the anti-obesity actions of green tea have been studied and it has been shown to significantly reduce glucose uptake accompanied by a decrease in translocation of glucose transporter 4 (GLUT4) in adipose tissue, while it stimulates the glucose uptake with GLUT4 translocation in skeletal muscle. Moreover, green tea suppresses the expression of peroxisome proliferator-activated receptor γ and the activation of sterol regulatory element binding protein-1 in adipose tissue. Thus, the possible mechanisms of the anti-obesity actions of green tea are the modulation of the glucose uptake system in adipose tissue and skeletal muscle and suppression of the expression and/or activation of adipogenesis-related transcription factors [55] .
Garcinia cambogia (Guttiferae): G. cambogia, also known as Indian kola, is traditionally used as a digestive, carminative and food preservative. Leaves and fruits (mainly fruit rind) contain up to 30% of (-)-hydroxycitric acid (53) (HCA) as their chief active constituent. HCA can be obtained also from other varieties, like G. indica and G. atroviridis. HCA is a potent inhibitor of ATP-citrate lyase, which is a key extra mitochondrial enzyme, catalyzing the cleavage of citrate to oxaloacetate acetyl-CoA. This inhibitory action reduces the acetyl-CoA pool, thus limiting the availability of the two carbon units required for the initial steps of fatty acid and cholesterol biosynthesis and promotes fatty acid oxidation. Hunger suppression caused by HCA occurs through release of serotonin (5-HT) from the serotonergic neurons in the brain, increasing the availability of 5-HT to its receptors and reducing the reuptake of serotonin. The flavonoid content of Garcinia inhibits HMG-CoA reductase, where fecal bile acid excretion is elevated at the same time [56] [57] [58] [59] .
The animal and human data suggest that intake of HCA at levels up to 2800 mg/ day is safe for human consumption. Higher doses are highly toxic to the testis [56] . Rubus idaeus (Rosaceae): Raspberry (European red raspberry, R. idaeus) is one of the oldest fruits known to people and has been used throughout the centuries for nutritional and medicinal purposes. Raspberry ketone [4-(4-hydroxyphenyl) butan-2-one] (RK) (54), one of the major aromatic compounds of raspberry, has a structure similar to those of capsaicin and synephrine, compounds known to exert anti-obese actions and alter lipid metabolism. Thus RK was evaluated for its antiobesity action and shown to alter lipid metabolism, or more specifically, in increasing norepinephrine-induced lipolysis in white adipocytes [60] .
Capsicum annum (Solanaceae): C. annum contains the neurotoxin capsaicin (55) that has a very mild effect on alteration of feeding patterns. No long term effect on body weight loss has been noted [61] .
Gymnema sylvestre (Asclepiadaceae): This is an antidiabetic herb, which probably helps to promote weight loss through its ability to reduce cravings for sweets and control blood sugar levels. It also reduces carbohydrate intake from the intestine [62, 63] .
Glycyrrhiza glabra (Leguminosae): Visceral obesity might be generated due to over activity of glucocorticoid hormones (cortisol), as in the case of Cushing's syndrome. Cortisol has the stimulatory effects on the differentiation of preadiposite tissues to mature adipocytes. G. glabra contains glycyrrhetinic acid (56) , which inhibits 11β-hydroxysteroid dehydrogenase (11 β-HSD), an enzyme responsible for the formation of cortisol and may have a role in treating obesity associated with cortisol excess [64, 65] .
Trigonella foenum-graecum (Fabaceae): T. foenumgraecum or methi seeds usually reduce 15-33% of total serum cholesterol. It does not reduce plasma lipid level in normal healthy persons, but causes significant reduction of blood lipids in patients having coronary artery disease and patients with type II diabetes mellitus [66] . An ethanolic extract of fenugreek seeds, containing saponins, lowered plasma cholesterol by 18-26%, probably due to inhibition of cholesterol reabsorption from the intestine. The remaining desaponified portion also produced a significant antihypercholesterolemic effect. Trigonelline (57), the major alkaloid of fenugreek, is also responsible for hypocholesterolemic activity.
Allium sativum (Liliaceae):
A. sativum reduces average serum cholesterol by around 13-14%, whereas the statin drugs reduce it by 20-30%. Watersoluble garlic extracts have been shown to inhibit multiple steps in cholesterol biosynthesis. The inhibition occurs, in the earlier steps, at the HMG-CoA reductase level, and at a later stage involving lanosterol α -demethylase in higher concentrations [67] . Alliin (58) (S-allylcysteine sulphoxide), the main sulphur containing compound in garlic, is less active per se, but it produces significant lipid lowering action only when it is enzymatically converted into allicin (diallyl thiosulphinate). Other active compounds in the aqueous extract are S-allyl cysteine, diallyl disulfide, diallyl trisulfide and dipropyl disulfide, which depressed cholesterol biosynthesis by 10-25% at low concentrations [68] . Ajoene (59) , another component of A. sativum, is much more potent than allicin. The saponin fraction (containing protoeruboside-B (60) and eruboside-B (61) is also responsible for the cholesterol lowering action of garlic, probably by inhibiting cholesterol absorption [69] .
Commiphora mukul (Burseraceae): Resin of the Indian guggul tree, a small thorny plant indigenous to the Indian sub-continent and parts of the Near East has been in use in India since 600 B.C. for a variety of ailments and was approved for cholesterol lowering treatment in India in 1987 [70] . The ethyl acetate fraction of the gum resin, designed as guggulipid, is known for exhibiting lipid-lowering activity in normal and hyperlipidemic rats, rabbits and monkeys [71] [72] [73] [74] . It reduces LDL cholesterol by about 15-18% and triglyceride by about 25%-30%. Human clinical trials data show that the average fall in serum cholesterol and triglycerides was 11 and 16.8%, respectively with guggulipid, whereas clofibrate (Atromid-S) reduced these values by 10 and 21.6%, respectively. The latter had no effect on HDL-cholesterol, which was increased by guggulipid in 60% of cases [75] . Guggul also has thyroid stimulating activity, which may lead to blood-lipid lowering as well as body weight loss. It increases triiodothyronin (T 3 ) concentration in the periphery, which indicates its possible influence in the thermogenic process [76, 77] . Dev and co-workers carried out in depth studies on the phytochemistry of resins of the guggul plant [78, 79] . In 1971, two pregnane derivatives, namely Z-guggulsterone (62) and E-guggulsterone (63) , were identified as the key ingredients responsible for the hypolipidemic activity. Both the isomers are equiactive [80, 81] . They are shown to act through an antagonizing action to the bile acid induced farnesoid X receptor (FXR), which in turn increases the cholesterol 7α-hydroxylase activity, the rate limiting enzyme for the conversion of cholesterol to bile acids with a net effect of lowering the circulating cholesterol level [82] .
Zingiber officinale (Zingiberaceae): This is one of the world's best-known spices and universally used for its health benefits. Ginger oleoresin (1%) treatment produces serum and liver cholesterol lowering activity in hypercholesterolemic rats, whereas whole ginger (10% dry weight basis) has no immediate effect on serum cholesterol. Ginger possibly stimulates the conversion of cholesterol into bile acids by stimulating hepatic cholesterol 7α hydroxylase activity [83] . It also increases the activity of LDL-receptor. (E)-8β,17-Epoxylabd-12ene-15,16-dial, isolated from the rhizome of ginger, is responsible for inhibition of cholesterol biosynthesis [84] . The aqueous extract of ginger has been shown to inhibit pancreatic lipase, body weight gain in mice and significantly reduce the adipose tissue weight. The mechanism suggested for the antiobesity action is the inhibition by its active constituents of dietary fat absorption from the intestine [85] . The methanolic and ethyl acetate extracts of dried rhizomes (250 mg/kg, body wt) have significant activity in controlling the elevated plasma 
lipid profile and body weight in hyperlipidemic rats. The lipid lowering potential of ginger is comparable to that of gemfibrozil [83] Curcuma longa (Zingiberaceae): C. longa reduces blood cholesterol and triglyceride level significantly, mediated through high bile acid production by stimulating cholesterol 7 α-hydroxylase activities. No effect on HMG -CoA reductase has been seen [86] .
Emblica officinalis (Euphorbiaceae):
In cholesterolfed rabbits, the fresh juice of E. officinalis fruits has been shown to reduce serum cholesterol, triglyceride, phospholipids and LDL levels by 82%, 66%, 77% and 90%, respectively and raise the HDL ratio by up to 60%. The action is supposed to be mediated by ascorbic acid. The flavonoids of the fruit have significant inhibitory activity on HMG-CoA reductase [87, 88] Cynara scolymus (Asteraceae): Artichoke is widely cultivated in Europe and America and its sprout is eaten as a vegetable. The leaves are used for the treatment of hepatitis and hyperlipidemia in European traditional medicine. Aqueous extracts of artichoke leaves inhibit cholesterol biosynthesis in the cultured rat hepatocyte model in vitro, as well as increasing bile acid excretion and reducing total blood cholesterol by 18.5% [89] [90] [91] . The sesquiterpenes isolated from the artichoke are primarily responsible for the activity, which is mainly produced by cynarin (64) (1,5-dicaffeoylquinic acid isomer), the major compound of the aqueous extract. The methanolic extract also shows antihyperlipidemic activity. The sesquiterpenes cynaropicrin (65), aguerin B (66), and grosheimin (67) were isolated as antihyperlipidemic compounds from the methanolic extract. Further studies indicated that the oxygen functionality at 3 and 8 positions and exo-methylene moiety in α-methylene-γbutyrolactone ring is essential for the activity of these guaiane-type sesquiterpenes [92] .
Plantago ovata (Plantaginaceae): Psyllium husk reduces plasma LDL cholesterol and increases HDL levels in patients with Type II diabetes mellitus. The lipid lowering action of psyllium husk is offered by two mechanisms, first the reduction of cholesterol absorption from the intestine and secondly by increasing bile acid production [93, 94] .
Crataegus oxycantha (Rosaceae): Aqueous extracts of C. oxycantha or hawthorn berry reduce total serum cholesterol and triglycerides by about 10-13%. It basically increases LDL receptor activity, suppresses cholesterol biosynthesis and enhances cholesterol degradation to bile acids [95] .
Terminalia arjuna (Combretaceae)
: This is traditionally used as a cardiotonic. An ethanolic extract of the tree bark has been shown to reduce total and LDL cholesterol (no change in HDL cholesterol) in rabbits fed on an atherogenic diet [96] . The extract also reduced the serum triglyceride level. In a study where T. arjuna, T. belerica and T. chebula were fed to cholesterol fed rabbits, T. arjuna was found to be the most potent hypolipidemic agent of the three [97] .
Ficus bengalensis (Moraceae): Treatment with an aqueous extract of the bark of F. bengalensis (banyan tree), decreased serum cholesterol by 59%, triacylglycerol by 54% and LDL + VLDL-cholesterol by 60% in hypocholesterolemic rabbits. In addition, treatment with the same extract led to a decrease in lipid peroxidation [98] .
Myristica fragrans (Myristicaceae): M. fragrans or nutmeg is usually used as a carminative. An ethanolic extract of nutmeg seed produced a significant decrease in blood lipid level (no effect in HDL cholesterol) in cholesterol-fed rabbits. The extract was found to contain a high amount of pectin (0.5%), which is an antioxidant, and niacin (1.4 mg/100 g), which has hypolipidemic action [99] .
Tribulus terrestris (Zygophyllaceae): Saponins from gokhru or T. terrestris can significantly lower total serum cholesterol, LDL and triglyceride levels in diet-induced hyperlipidemia in mice [100] .
Hoodia:
The hoodia plant is found in the Kalahari Desert. The San hunters native to the desert find that hoodia, when eaten even in small quantities, causes the sensation of hunger to cease. The active compound, known as P57, was isolated and patented by Phytopharm (UK), which specializes in therapeutic botanical compounds. P57 does not cause breakdown of fatty tissue and is simply an appetite suppressant, markedly decreasing the calorie intake of treated patients. It is now under development by Phytopharm for the treatment of obesity and metabolic syndrome and, if approved, is set to become a blockbuster [1] .
Plant sterols
Plant sterols and their analogues have been shown to reduce plasma cholesterol by decreasing the absorption of cholesterol from the gut and thus may potentially reduce the risk of developing atherosclerosis, CHD and even obesity. FM-VP4 (68) is a water soluble chemical derivative of phytosterol show to reduce cholesterol absorption. The effect of FM-VP4 on pancreatic lipase was studied and it was shown that it does not inhibit pancreatic lipase. In several of these studies, it was noted that FM-VP4 administration causes a decrease in body weight without any observable liver or kidney toxicity or changes in food or water intake. FM-VP4 displayed potential weight-loss and cholesterol-lowering properties in animals on both high fat and low fat diets. These results warrant further investigation in a dose response study to see if FM-VP4 will show as potent anti-obesity effects in more clinically relevant doses [101, 102] .
Hyperlipidemia associated with diabetes
The level of serum lipid is usually raised in diabetes. The high concentration of serum lipids in diabetes is found mainly due to the inactivity or low circulating level of insulin and uninhibited mobilization of free fatty acids from the peripheral depots by other hormones.
Momordica charantia (Cucurbitaceae):
Methanolic extracts of fruits of M. charantia, which contains sterols like charantin and momordicin, have shown significant reduction of plasma cholesterol and triglycerides in male albino rats. The activity is mediated through thyrogenic response, as well as by reducing cholesterol absorption. However, the extracts have no triglyceride lowering property. Triiodothyronine (T 3 ) enhances insulin action, which in turn enhances glucose transport into the tissue cells. Once glucose is available for ATP production, it reduces mobilization of triglycerides inside the cells, and hence reduces the blood triglyceride level. At the same time, the seeds have been found to contain certain peptides, which have antilipolytic and lipogenic action [103, 104] .
Tinospora cordifolia (Menispermaceae):
The aqueous extract of T. cordifolia root has been shown to produce a hypolipidemic effect in alloxan treated diabetic rats, which can be directly correlated with the reduction of the blood glucose concentration [105] .
Eugenia jambolana:
An ethanolic extract of seeds of E. jambolana, commonly known as jammun, causes significant glucose lowering, as well as lipid lowering activity in alloxan-treated diabetic rabbits. The lipid lowering action is mediated through increased sensitivity of insulin. The extract also inhibits HMG-CoA reductase activity [106] .
Despite the great strides that have been made in understanding the physiology of obesity and the various mechanisms underlying it, it is becoming a major health problem worldwide. Obesity is going to be a severe problem in India like other areas, such as North America, Australia and Europe due to the impact of the dangerously spreading life style changes and to some extent hereditary factors. Childhood and adult obesity have imposed serious thought on the social thinkers on how to cope with future societal problems. The Indian traditional systems of medicine, particularly Ayurveda, records a number of medicaments/medicinal plants that can be scientifically validated to combat afflictions like obesity and hyperlipidemia. Recent developments in understanding the pathophysiology of the disease process have opened up new avenues to identify and develop novel therapies to combat obesity. Concurrently, phytochemicals identified from traditional medicinal plants are presenting an exciting opportunity for the development of new types of therapeutics. Thus there is an urgent need to identify the indigenous natural sources to study in detail their potential on different newly identified targets in order to develop them as new therapeutic agents.
